SARS-CoV-2 Convalescent Sera Binding and Neutralizing Antibody Concentrations Compared with COVID-19 Vaccine Efficacy Estimates against Symptomatic Infection

Previous COVID-19 vaccine efficacy (VE) studies have estimated neutralizing and binding antibody concentrations that correlate with protection from symptomatic infection; how these estimates compare to those generated in response to SARS-CoV-2 infection is unclear. Here, we assessed quantitative neu...

Descripción completa

Detalles Bibliográficos
Autores principales: Schuh, Amy J., Satheshkumar, Panayampalli S., Dietz, Stephanie, Bull-Otterson, Lara, Charles, Myrna, Edens, Chris, Jones, Jefferson M., Bajema, Kristina L., Clarke, Kristie E. N., McDonald, L. Clifford, Patel, Sadhna, Cuffe, Kendra, Thornburg, Natalie J., Schiffer, Jarad, Chun, Kelly, Bastidas, Monique, Fernando, Manory, Petropoulos, Christos J., Wrin, Terri, Cai, Suqin, Adcock, Dot, Sesok-Pizzini, Deborah, Letovsky, Stanley, Fry, Alicia M., Hall, Aron J., Gundlapalli, Adi V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430572/
https://www.ncbi.nlm.nih.gov/pubmed/35856710
http://dx.doi.org/10.1128/spectrum.01247-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430572/
https://www.ncbi.nlm.nih.gov/pubmed/35856710
http://dx.doi.org/10.1128/spectrum.01247-22

Ejemplares similares